慢性肾脏病患者肺动脉高压的诊断与管理
本文综述慢性肾脏病(CKD)患者肺动脉高压(PH)的定义、病理生理与分类,并描述诊断与管理策略,涵盖依赖肾脏替代治疗的肾衰竭患者。CKD可能通过尿毒症毒素等直接诱发肺循环功能障碍,尽管PH在CKD中高发且与不良预后相关,但缺乏高质量证据指导诊疗。
要点
- CKD患者PH高发且与不良预后相关,但诊断和管理缺乏高质量证据。
- 未需肾脏替代治疗的CKD患者,容量管理及治疗PH危险因素至关重要。
- 血透患者反复低血压影响容量控制时,可考虑转为腹膜透析。
核心结论
- CKD患者中肺动脉高压高发且与不良预后相关,但诊断和管理策略缺乏高质量证据。
研究设计与样本
- 综述,总结PH定义、病理生理、分类及CKD患者(含肾衰竭接受肾脏替代治疗者)的诊断与管理策略。
主要发现
- CKD可能通过尿毒症毒素、炎症、内皮功能障碍和血管调节异常直接诱发肺循环功能障碍和重塑。
- 在PH分类中,CKD相关PH被归入机制不明确或多因素的一组,尽管多数病例可能由潜在心血管疾病所致。
临床怎么用
- 未需肾脏替代治疗的CKD患者,应进行容量管理并治疗PH的潜在危险因素。
- 血透患者若反复低血压妨碍最佳容量控制,可考虑转为腹膜透析。
局限性
- CKD患者PH的诊断和管理策略缺乏高质量证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pulmonary hypertension (PH) is a highly prevalent and important condition in adults with chronic kidney disease (CKD). In this review, we summarize the definition of PH, discuss its pathophysiology and classifications, and describe diagnostic and management strategies in patients with CKD, including those with kidney failure treated by kidney replacement therapy. In the general population, PH is classified into 5 groups based on clinical presentation, pathology, hemodynamics, and management strategies. In this classification system, PH in CKD is placed in a diverse group with unclear or multifactorial mechanisms, although underlying cardiovascular disease may account for most cases. CKD may itself directly incite pulmonary circulatory dysfunction and remodeling through uremic toxins, inflammation, endothelial dysfunction, and altered vasoregulation. Despite several studies describing the higher prevalence of PH in CKD and kidney failure, along with an association with poor outcomes, high-quality evidence is not available for its diagnostic and management strategies in those with CKD. In CKD not requiring kidney replacement therapy, volume management along with treatment of underlying risk factors for PH are critical. In those receiving hemodialysis, options are limited and transition to peritoneal dialysis may be considered if recurrent hypotension precludes optimal volume control.
引用
- Walther CP, Nambi V, Hanania NA, et al. Diagnosis and Management of Pulmonary Hypertension in Patients With CKD. Am J Kidney Dis. 2020. PMID: 32199709. doi:10.1053/j.ajkd.2019.12.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。